Sponsored by:
Packaging and labeling support for a global cell therapy program
As cell and gene therapies rapidly expand toward global patient populations, the need for highly reliable, multi-temperature packaging and labeling solutions has never been greater.
Modern clinical programs must meet aggressive timelines, navigate global regulatory differences, and ensure that therapies—whether refrigerated or cryogenic—arrive safely and consistently at clinical sites worldwide.
This complexity demands more than basic cold-chain support; it requires a partner capable of precision, customization, and flawless coordination.
A leading late-stage cell therapy developer recently faced this challenge as it prepared to scale across the US, Canada, Australia, and future sites in the EU and South Korea. The therapies in its pipeline required two distinct storage modalities: unlabeled vials stored at refrigerated temperatures and product requiring cryogenic LNâ conditions. With strict just-in-time (JIT) requirements and diverse global destinations, the developer needed a solution that could be tailored, validated, and executed with absolute speed and reliability.
